Harmony Biosciences Holdings CFO Sandip Kapadia's 2021 pay jumps 171% to $6.2M
Harmony Biosciences Holdings reports 2021 executive compensation
By ExecPay News
Published: April 8, 2022
Harmony Biosciences Holdings reported fiscal year 2021 executive compensation information on April 8, 2022.
In 2021, six executives at Harmony Biosciences Holdings received on average a compensation package of $1.7M, a 40% decrease compared to previous year.
Average pay of disclosed executives at Harmony Biosciences Holdings
Sandip Kapadia, Chief Financial Officer, received $6.2M in total. 60% of Kapadia's compensation, or $3.8M, was in option awards. Kapadia also received $175K in bonus, $185K in non-equity incentive plan, $354K in salary, $1.7M in stock awards, as well as $2.6K in other compensation.
Jeffrey Dierks, EVP and Chief Commercial Officer, received a compensation package of $1.6M, which decreased by 40% compared to previous year. 62% of the compensation package, or $1M, was in option awards.
John C. Jacobs, Chief Executive Officer, earned $886K in 2021, a 73% decrease compared to previous year.
Jeffrey Dayno, Chief Medical Officer, received $703K in 2021, which decreases by 74% compared to 2020.
Andrew Serafin, EVP and Chief Strategy Officer, earned $571K in 2021.
Susan Drexler, Chief Financial Officer, received $369K in 2021.
Related executives
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
Sandip Kapadia
Harmony Biosciences Holdings
Chief Financial Officer
Jeffrey Dayno
Harmony Biosciences Holdings
Chief Medical Officer
Jeffrey Dierks
Harmony Biosciences Holdings
EVP and Chief Commercial Officer
Andrew Serafin
Harmony Biosciences Holdings
EVP and Chief Strategy Officer
Susan Drexler
Harmony Biosciences Holdings
Chief Financial Officer
You may also like
Source: SEC filing on April 8, 2022.